Transaction expected to approximately triple NEXGEL’s annual revenue to about $35 million and is expected to make the Company immediately ...

Consideration for portfolio will consist of a $15 million upfront cash payment and potentially an additional $20 million in milestone payments ...

Biomaterials are specifically engineered to support tissue, nerve and muscle regeneration across the body, yet physicians and ...

NexGel Inc. NXGL on Tuesday agreed to license and acquire a portfolio of commercial-stage regenerative biomaterial products from Celularity, Inc. CELU, a regenerative and cellular medicine company.

NEXGEL, Inc. (NASDAQ:NXGL) has signed an asset purchase and exclusive licensing agreement with Celularity, Inc. to obtain rights to Celularity’s commercial-stage regenerative biomaterials portfolio, ...

In a bid to reduce the amount of plastic created each year by the electronic component industry, the connector manufacturers Harwin and Nicomatic have partnered with biomaterial innovation specialist ...

This Experiment will Examine TETRANITE’S Ability to Regenerate Bone under the Condition of Microgravity which Simulates Osteoporosis KENNEDY SPACE CENTER, Fla.--(BUSINESS WIRE)--RevBio, Inc., ...

An announcement from NexGel Inc ( (NXGL) ) is now available.

Regenerative medicine is a promising research area that focuses on restoring and repairing diseased or damaged cells, tissue, or organs. It is a branch of medicine comprising tissue engineering and ...

A study published in Materials Horizons reports that Penn State researchers have developed a biomaterial capable of mimicking key behaviors of extracellular matrices (ECMs). This material has ...

This Collection supports and amplifies research related to SDG 3 - Good Health & Well-Being. Biomaterials for Regenerative Engineering is an interdisciplinary research field that combines materials ...